![Allan Wehnert](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Allan Wehnert
Plus aucun poste en cours
Health Technology
Profil
Allan Wehnert is the founder of Orocidin AS, established in 2023, and holds the title of Chief Executive Officer.
Former jobs include VP-R&D Project Strategy & Portfolio Management at H.
Lundbeck A and Senior Vice President-Clinical, R&D Strategy at Initiator Pharma A.
Postes actifs de Allan Wehnert
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Allan Wehnert
| Sociétés | Poste | Fin |
|---|---|---|
| INITIATOR PHARMA A/S | Directeur Technique/Scientifique/R&D | - |
| H. LUNDBECK A/S | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Initiator Pharma A/S
 Initiator Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs to unmet medical needs within the central & peripheral nervous system | Health Technology |
